ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 100 filers reported holding ENDOCYTE INC in Q4 2014. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $327,000 | +263.3% | 18,392 | +182.6% | 0.00% | – |
| Q2 2018 | $90,000 | +23.3% | 6,509 | -18.6% | 0.00% | – |
| Q1 2018 | $73,000 | +143.3% | 8,000 | +12.8% | 0.00% | – |
| Q4 2017 | $30,000 | +275.0% | 7,092 | +18.2% | 0.00% | – |
| Q3 2017 | $8,000 | -20.0% | 6,000 | -6.0% | 0.00% | – |
| Q2 2017 | $10,000 | -44.4% | 6,380 | -10.5% | 0.00% | – |
| Q1 2017 | $18,000 | -57.1% | 7,131 | -57.1% | 0.00% | – |
| Q4 2016 | $42,000 | +121.1% | 16,622 | +177.0% | 0.00% | – |
| Q3 2016 | $19,000 | -34.5% | 6,000 | -34.1% | 0.00% | – |
| Q2 2016 | $29,000 | +45.0% | 9,099 | +41.1% | 0.00% | – |
| Q1 2016 | $20,000 | -58.3% | 6,450 | -46.5% | 0.00% | – |
| Q4 2015 | $48,000 | +2.1% | 12,056 | +20.0% | 0.00% | – |
| Q3 2015 | $47,000 | +46.9% | 10,046 | +64.7% | 0.00% | – |
| Q2 2015 | $32,000 | -37.3% | 6,100 | -25.0% | 0.00% | – |
| Q1 2015 | $51,000 | -53.6% | 8,138 | -53.5% | 0.00% | – |
| Q4 2014 | $110,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corbenic Partners LLC | 32,639 | $83,000 | 0.09% |
| Anson Funds Management LP | 108,426 | $276,000 | 0.09% |
| Leisure Capital Management | 30,038 | $77,000 | 0.07% |
| HIGHLAND CAPITAL MANAGEMENT LP | 461,561 | $1,177,000 | 0.06% |
| Teza Capital Management LLC | 14,542 | $37,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 821,543 | $2,095,000 | 0.04% |
| Cribstone Capital Management, LLC | 28,141 | $63,000 | 0.04% |
| RMB Capital Management, LLC | 243,385 | $621,000 | 0.03% |
| Acrospire Investment Management LLC | 26,061 | $66,000 | 0.03% |
| TWO SIGMA SECURITIES, LLC | 26,758 | $68,000 | 0.02% |